193 related articles for article (PubMed ID: 8612202)
1. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation.
Gijbels K; Brocke S; Abrams JS; Steinman L
Mol Med; 1995 Nov; 1(7):795-805. PubMed ID: 8612202
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of Interleukin-9 Decreasing Mast Cells Infiltration in Experimental Autoimmune Encephalomyelitis.
Yin JJ; Hu XQ; Mao ZF; Bao J; Qiu W; Lu ZQ; Wu HT; Zhong XN
Chin Med J (Engl); 2017 Apr; 130(8):964-971. PubMed ID: 28397727
[TBL] [Abstract][Full Text] [Related]
3. Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
Savarin C; Hinton DR; Valentin-Torres A; Chen Z; Trapp BD; Bergmann CC; Stohlman SA
J Neuroinflammation; 2015 Apr; 12():79. PubMed ID: 25896970
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
5. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
Samoilova EB; Horton JL; Chen Y
Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.
Agnello D; Bigini P; Villa P; Mennini T; Cerami A; Brines ML; Ghezzi P
Brain Res; 2002 Oct; 952(1):128-34. PubMed ID: 12363412
[TBL] [Abstract][Full Text] [Related]
7. B cells are required for sunlight protection of mice from a CNS-targeted autoimmune attack.
Kok LF; Marsh-Wakefield F; Marshall JE; Gillis C; Halliday GM; Byrne SN
J Autoimmun; 2016 Sep; 73():10-23. PubMed ID: 27289166
[TBL] [Abstract][Full Text] [Related]
8. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats.
Diab A; Zhu J; Xiao BG; Mustafa M; Link H
J Neuropathol Exp Neurol; 1997 Jun; 56(6):641-50. PubMed ID: 9184655
[TBL] [Abstract][Full Text] [Related]
9. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination.
Furlan R; Poliani PL; Galbiati F; Bergami A; Grimaldi LM; Comi G; Adorini L; Martino G
Hum Gene Ther; 1998 Nov; 9(17):2605-17. PubMed ID: 9853527
[TBL] [Abstract][Full Text] [Related]
11. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
12. Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis.
Quintana A; Müller M; Frausto RF; Ramos R; Getts DR; Sanz E; Hofer MJ; Krauthausen M; King NJ; Hidalgo J; Campbell IL
J Immunol; 2009 Aug; 183(3):2079-88. PubMed ID: 19597000
[TBL] [Abstract][Full Text] [Related]
13. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M
Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544
[TBL] [Abstract][Full Text] [Related]
14. Th9 cells in the pathogenesis of EAE and multiple sclerosis.
Elyaman W; Khoury SJ
Semin Immunopathol; 2017 Jan; 39(1):79-87. PubMed ID: 27844107
[TBL] [Abstract][Full Text] [Related]
15. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells.
Issazadeh S; Mustafa M; Ljungdahl A; Höjeberg B; Dagerlind A; Elde R; Olsson T
J Neurosci Res; 1995 Apr; 40(5):579-90. PubMed ID: 7602612
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
Popovic M; Stanojevic Z; Tosic J; Isakovic A; Paunovic V; Petricevic S; Martinovic T; Ciric D; Kravic-Stevovic T; Soskic V; Kostic-Rajacic S; Shakib K; Bumbasirevic V; Trajkovic V
J Neurochem; 2015 Oct; 135(1):125-38. PubMed ID: 26083644
[TBL] [Abstract][Full Text] [Related]
17. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
18. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.
Stanisavljević S; Dinić M; Jevtić B; Đedović N; Momčilović M; Đokić J; Golić N; Mostarica Stojković M; Miljković Đ
Front Immunol; 2018; 9():942. PubMed ID: 29770137
[TBL] [Abstract][Full Text] [Related]
20. β-Caryophyllene ameliorates the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Fontes LBA; Dias DDS; Aarestrup BJV; Aarestrup FM; Da Silva Filho AA; Corrêa JODA
Biomed Pharmacother; 2017 Jul; 91():257-264. PubMed ID: 28463791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
